Sunnypharmtech Oral Products
Our oral pharmaceutical team has accumulated considerable capability and established several technology platforms in formulation development for U.S. ANDA submission. Several generic products have been developed and ANDAs submitted to U.S. FDA.
Our oral pharmaceutical team has accumulated considerable capability and established several technology platforms in formulation development for U.S. ANDA submission. Several generic products have been developed and ANDAs submitted to U.S. FDA.
| Ingredients | Dose | Dosage Form |
| Nitrofurantoin Mono/Macro | 75mg/25mg | Capsules |
| Aminocaproic Acid | 500mg and 1000mg | Tablets |
| New Projects | Dosage form | Indication |
| AMA-s | Oral solution | Blood anticoagulant |
| CTD | Tablets | Antihypertensive/Diuretic |
| PTD-T | Tablets | Procoagulant |
| FXT | Tablets | Obsessive-Compulsive Disorder |
| DXM | Suspension (OTC) | Antitussive |
Product R&D
